Search research articles
Contact Us
Filters
Showing results (171-180 of 343) with videos related to
Page
of 35
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 24, 2017
A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients
David R Fogelman, J Morris, L Xiao, et al.
Cancer Chemotherapy and Pharmacology
|
August 2, 2008
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma
Joanna M Brell, Smitha S Krishnamurthi, Milind Javle, et al.
JCO Precision Oncology
|
March 28, 2024
Comprehensive Immunogenomic Profiling of <i>IDH1-</i>/<i>2</i>-Altered Cholangiocarcinoma
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, et al.
Journal of Gastrointestinal Oncology
|
November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imaging
Jane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Hepatology (Baltimore, Md.)
|
September 12, 2021
The immunogenomic landscape of resected intrahepatic cholangiocarcinoma
Fernando Carapeto, Behnaz Bozorgui, Rachna T Shroff, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
February 13, 2023
Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes?
Reed I Ayabe, Natalia Paez-Arango, Jeannelyn S Estrella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2005
Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors
Marwan G Fakih, Patrick J Creaven, Nithya Ramnath, et al.
Journal of Clinical Pathology
|
October 27, 2015
Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets
Hwajeong Lee, Kai Wang, Adrienne Johnson, et al.
Digestive Diseases and Sciences
|
July 14, 2011
Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: single-center experience with 79 cases
Ashwani K Singal, William A Ross, Praveen Guturu, et al.
Scientific Reports
|
December 17, 2020
Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer
Reham Abdel-Wahab, Timothy A Yap, Russell Madison, et al.
Page
of 35
Search research articles
Search
Showing results (171-180 of 343) with videos related to
Sort By:
Page
of 35
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 24, 2017
A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients
David R Fogelman, J Morris, L Xiao, et al.
Cancer Chemotherapy and Pharmacology
|
August 2, 2008
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma
Joanna M Brell, Smitha S Krishnamurthi, Milind Javle, et al.
JCO Precision Oncology
|
March 28, 2024
Comprehensive Immunogenomic Profiling of <i>IDH1-</i>/<i>2</i>-Altered Cholangiocarcinoma
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, et al.
Journal of Gastrointestinal Oncology
|
November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imaging
Jane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Hepatology (Baltimore, Md.)
|
September 12, 2021
The immunogenomic landscape of resected intrahepatic cholangiocarcinoma
Fernando Carapeto, Behnaz Bozorgui, Rachna T Shroff, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
February 13, 2023
Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes?
Reed I Ayabe, Natalia Paez-Arango, Jeannelyn S Estrella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2005
Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors
Marwan G Fakih, Patrick J Creaven, Nithya Ramnath, et al.
Journal of Clinical Pathology
|
October 27, 2015
Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets
Hwajeong Lee, Kai Wang, Adrienne Johnson, et al.
Digestive Diseases and Sciences
|
July 14, 2011
Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: single-center experience with 79 cases
Ashwani K Singal, William A Ross, Praveen Guturu, et al.
Scientific Reports
|
December 17, 2020
Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer
Reham Abdel-Wahab, Timothy A Yap, Russell Madison, et al.
Page
of 35